Who can prescribe Mounjaro — and how the process works in the UK

Step 1: understanding who holds prescribing authority for Mounjaro

The authority to prescribe Mounjaro in the UK sits with three groups of clinicians: registered medical doctors (GPs and hospital consultants), dentists where clinically relevant, and GPhC-registered Independent Prescribers. The last group is the one most people encounter when using a regulated online pharmacy. Independent Prescribers are pharmacists or other allied health professionals who have completed an additional postgraduate prescribing qualification and are entered on the GPhC register specifically as Independent Prescribers, they can prescribe any medicine within their area of competence, including prescription-only weight-management treatments.

A common misconception is that prescriptions from online pharmacies are somehow a lesser category, signed off by software or rubber-stamped automatically. They are not. A GPhC-registered Independent Prescriber working for a regulated pharmacy carries exactly the same professional and legal responsibilities as a GP. Their name goes on the prescription. Their registration is at stake if they prescribe carelessly. You can verify any pharmacy's registration directly on the GPhC register, it takes about thirty seconds.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, personally. A real clinician reviews your answers the same day, not a bot, not a scoring algorithm. If something in your health picture gives them pause, they will contact you or decline rather than proceed. That is how it should work.

Step 2: what the prescriber is actually assessing

The clinical assessment for Mounjaro covers more ground than BMI alone. The licensed eligibility criteria (summarised clearly on the NHS tirzepatide page) set BMI thresholds of 30 or above, or 27 and above if at least one weight-related condition is present (such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnoea). Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. But the prescriber goes further than those numbers.

They review your current medicines for interactions. Tirzepatide slows gastric emptying, which affects how quickly some oral medicines are absorbed, oral contraceptive pill users, for instance, need additional contraception for the first four weeks of treatment and after each dose increase, a point explored in detail for people on corticosteroids in our supporting content. The prescriber also checks for contraindications: a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, a history of pancreatitis, and certain gastrointestinal conditions all require careful discussion before tirzepatide is appropriate. Pregnancy, breastfeeding, and trying to conceive rule it out entirely.

None of this is gatekeeping for its own sake. It is the clinical work that keeps you safe once treatment starts.

Step 3: the prescription and what comes next

Once a prescriber is satisfied that Mounjaro is clinically appropriate, they issue a prescription. For a regulated online pharmacy, that prescription feeds directly into the pharmacy's dispensing process, there is no separate paper script to manage or post anywhere. At nume, orders placed before 12pm Monday to Friday are dispatched the same day once approved and arrive free the next working day via DPD, in plain unbranded packaging.

The prescriber's involvement does not end at the prescription stage. Before any dose increase and before a repeat prescription is issued, the clinical picture is reviewed again. Evidence of current weight, any changes to medicines or health conditions, and how the previous dose was tolerated all feed into that review. If you are considering obtaining Mounjaro through an online route, this ongoing clinical oversight is the thing to look for, not just who signs the first prescription, but who reviews every subsequent one.

For broader context on the different weight-loss medicines available and how prescribing decisions are made across them, our weight-loss treatment overview covers the landscape clearly. You can also read more about how our clinical team approaches these assessments on the clinical team page.

NHS prescribing versus private prescribing: the practical distinction

GPs can prescribe Mounjaro on the NHS, but access is tightly phased. As of summer 2026, NHS tirzepatide is available to adults with a BMI of 40 or above and four or more specific weight-related conditions, with a second cohort (BMI 35–39.9 plus four conditions) activated in June 2026. Full details of how NICE's TA1026 recommendation is being rolled out sit on the NICE TA1026 page. GP participation in the new prescribing pathway is optional, so even eligible patients may find it unavailable at their practice.

Private prescribing through a regulated pharmacy like nume fills that gap. It does not require a referral or a wait. The cost context is worth understanding, our Mounjaro cost and pricing page sets out what a legitimate private price includes (consultation, prescription, treatment and delivery) versus what a suspiciously low price usually leaves out. Suitability is still decided clinically; a private route does not bypass the prescriber, it just removes the NHS queue.

If you have questions that go beyond what is covered here, our frequently asked questions page covers the most common ones, or you can reach our team directly. When you are ready to find out whether Mounjaro is right for you, the next step is straightforward, and if you are based in the north-west you can find out more on our Mounjaro Preston page.